Home/Filings/4/0001415889-22-003720
4//SEC Filing

Yuan Qing Sarah 4

Accession 0001415889-22-003720

CIK 0001821323other

Filed

Apr 3, 8:00 PM ET

Accepted

Apr 4, 4:50 PM ET

Size

5.5 KB

Accession

0001415889-22-003720

Insider Transaction Report

Form 4
Period: 2022-04-01
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-04-01+120,000120,000 total
    Exercise: $1.48Exp: 2032-03-06Common Stock (120,000 underlying)
Footnotes (1)
  • [F1]The option vests as to 25% of the underlying shares of common stock on March 7, 2023, the first anniversary of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each quarter following such date until the option is fully vested.

Issuer

Sigilon Therapeutics, Inc.

CIK 0001821323

Entity typeother

Related Parties

1
  • filerCIK 0001907487

Filing Metadata

Form type
4
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 4:50 PM ET
Size
5.5 KB